Malignancies after kidney transplantation: Hong Kong renal registry

American Journal of Transplantation

Volumn 12, Issue 11, 2012, Pages 3039-3046

  Cheung, C Y ^a   Lam, M F ^b   Chu, K H ^c   Chow, K M ^d   Tsang, K Y ^e   Yuen, S K ^f   Wong, P N ^g   Chan, S K ^h   Leung, K T ⁱ   Chan, C K ^j   Ho, Y W ^j   Chau, K F ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

^f Caritas Medical Centre Hong Kong   (Hong Kong)

^g KWONG WAH HOSPITAL   (Hong Kong)

^h PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

ⁱ TUEN MUN HOSPITAL   (Hong Kong)

^j UNITED CHRISTIAN HOSPITAL   (Hong Kong)

more..

Author keywords

incidence; kidney transplantation; malignancy

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CARCINOMA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HODGKIN DISEASE; HONG KONG; HUMAN; KAPOSI SARCOMA; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHODGKIN LYMPHOMA; NONMELANOMA SKIN CANCER; OVARY CARCINOMA; PANCREAS CARCINOMA; POSTTRANSPLANT MALIGNANCY; PRIORITY JOURNAL; PROSTATE CARCINOMA; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; STANDARDIZED MORTALITY RATIO; STOMACH CARCINOMA; THYROID CARCINOMA; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HONG KONG; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84868215129     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04209.x     Document Type: Article

References (31)

1. Birkeland SA, Storm HH, Lamm LU, et al,. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-189.
2. Hoshida Y, Tsukuma H, Yasunaga Y, et al,. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517-520.
3. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP,. Risk of neoplasia in renal transplant recipients. Lancet 1995; 346: 403-406.
4. Kasiske BL, Snyder JJ, Gilbertson DT, et al,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913.
5. Villeneuve PJ, Schaubel DE, Fenton SS, et al,. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7: 941-948.
6. Vajdic CM, McDonald SP, McCredie MR, et al,. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
7. Hwang JK, Moon IS, Kim JI,. Malignancies after kidney transplantation: a 40-year single-center experience in Korea. Transplant Int 2011; 24: 716-721.
8. Adami J, Gabel H, Lindelof B, et al,. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227.
9. Collett D, Mumford L, Banner NB, Neuberger J, Watson C,. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10: 1889-1896.
10. Wu MJ, Lian JD, Yang CR, et al,. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 2004; 43: 1091-1097.
11. Feng WW, Wang TN, Chen HC, et al,. Malignancies after renal transplantation in southern Taiwan: experience in one center. BJU Int 2007; 99: 825-829.
12. Li XB, Xing NZ, Wang Y, et al,. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 2008; 15: 53-57.
13. Li WH, Chen YJ, Tseng WC, et al,. Malignancies after renal transplantation in Taiwan: a nationwide population-based study. Nephrol Dial Transplant 2011; 27: 833-839.
14. Kiberd BA, Rose C, Gill JS,. Cancer mortality in kidney transplantation. Am J Transplant 2009; 9; 1868-1875.
15. th revision. 2007.
16. Hong Kong Cancer Registry, Hospital Authority. http://www3.ha.org.hk/ cancereg/
17. Engels EA, Pfeiffer RM, Fraumeni JF, et al,. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901.
18. Moosa MR,. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine 2005; 84: 12-22.
19. Kishikawa H, Ichikawa Y, Yazawa K, et al,. Malignant neoplasm in kidney transplantation. Int J Urol 1998; 5: 521-525.
20. Sun Q, Li X, Cheng D, et al,. Special malignancy pattern in Chinese renal transplantation recipients: a single center experience and literature review. Asian Pac J Cancer Prev 2011; 12: 3347-3351.
21. Van Leeuwen MT, Grulich AE, Webster AC, et al,. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 2009; 114: 630-637.
22. Quinlan SC, Pfeiffer RM, Morton LM, Engels EA,. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 2011; 86: 206-209.
23. Goh A, Vathsala A,. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant 2011; 11: 86-92.
24. Layman AB, Engels EA,. Kidney and bladder cancers among people with AIDS in the United States. J Acquir Immune Defic Syndr 2008; 48: 365-367.
25. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M,. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 2011; 204: 217-223.
26. Yuan Q, Wang M, Wang M, Zhang Z, Zhang W,. Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis. Mol Biol Rep 2012; 39: 3109-3115.
27. Han SX, Wang L, Wu DQ,. The association between UGT1A7 polymorphism and cancer risk: A meta-analysis. Cancer Epidemiol 2012 (Epub ahead of print).
28. Ju MK, Joo DJ, Kim SJ, et al,. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience. Transplant Int 2009; 22: 644-653.
29. Lee IS, Kim TH, Kim YH, Yook JH, Kim BS, Han DJ,. Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg 2012; 36: 1806-1810.
30. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL,. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-335.
31. McDonald S, Excell L, Livingston B,. Deaths. 33rd Annual Report. Australia and New Zealand Dialysis and Transplant Registry 2011.